Abstract
The POT1 protein binds and protects telomeres. Germline variants in the POT1 gene have recently been shown to be associated with risk of developing tumors in different tissues such as familial chronic lymphocytic leukemia, colorectal, glioma and melanoma tumors. Recently, we uncovered a variant in the POT1 gene (p.R117C) as causative of familial cardiac angiosarcomas (CAS) in Li-Fraumeni-like (LFL) syndrome families. Our in silico studies predicted that this protein had lost the ability to interact with TPP1 and single-stranded DNA. In vitro studies corroborated this prediction and showed that this lack of function leads to abnormally long telomeres. To better understand the POT1 gene and its role with tumorigenesis, we extended the study to LFL (with and without members affected with angiosarcomas (AS)) and sporadic AS and cardiac sarcomas. We found POT1 variants in the 20% of the families with members affected with AS and 10% of sporadic AS and sarcomas. In silico studies predicted that these new variants were damaging in the same manner as previously described for the POT1 p.R117C variants. The wide spectrum of variants in the POT1 gene leading to tumorigenesis in different tissues demonstrates its general importance. Study of the POT1 gene should be considered as routine diagnostic in these cancers.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Palm W, de Lange T : How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42: 301–334.
Lei M, Podell ER, Cech TR : Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat Struct Mol Biol 2004; 11: 1223–1229.
Bainbridge MN, Armstrong GN, Gramatges MM et al: Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst 2014; 107: dju384.
Robles-Espinoza CD, Harland M, Ramsay AJ et al: POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 2014; 46: 478–481.
Shi J, Yang XR, Ballew B et al: Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet 2014; 46: 482–486.
Chubb D, Broderick P, Dobbins SE et al: Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat Commun 2016; 7: 11883.
Speedy HE, Kinnersley B, Chubb D et al: Germline mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. Blood 2016; 128: 2319.
Ramsay AJ, Quesada V, Foronda M et al: POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet 2013; 45: 526–530.
Calvete O, Martinez P, Garcia-Pavia P et al: A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families. Nat Commun 2015; 6: 8383.
Kunze K, Spieker T, Gamerdinger U et al: A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells. Cancer Res 2014; 74: 6173–6183.
Karami S, Han Y, Pande M et al: Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer 2016; 139: 2655–2670.
Acknowledgements
GB’s lab is supported by the INCa, the French National Cancer Institute and the ARC Foundation for Cancer Research. CL’s lab is funded by the Asociación Española Contra el Cáncer, Spanish Health Research Foundation, Carlos III Health Institute (PIE13/00022 and PI16/00563), Catalan Health Institute and Autonomous Government of Catalonia. AB’s lab is funded by Deutsche Forschungsgemeinschaft (BR1238/8-2). JB’s lab is partially funded by CIBERER, H2020 BRIDGES project and by the Spanish Ministry of Health supported by FEDER funds (PI16/00440).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Calvete, O., Garcia-Pavia, P., Domínguez, F. et al. The wide spectrum of POT1 gene variants correlates with multiple cancer types. Eur J Hum Genet 25, 1278–1281 (2017). https://doi.org/10.1038/ejhg.2017.134
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2017.134
This article is cited by
-
POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program
European Journal of Human Genetics (2024)
-
Genetic Predisposition to Sarcoma: What Should Clinicians Know?
Current Treatment Options in Oncology (2024)
-
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma
Communications Biology (2023)
-
The European Journal of Human Genetics is turning 30: a selection of major cancer genetics papers published by the Journal
European Journal of Human Genetics (2022)
-
A Novel CHEK2 Variant Identified by Next-Generation Sequencing in an Italian Family with Li-Fraumeni Syndrome: Case Report
SN Comprehensive Clinical Medicine (2022)